AMAG PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT (DEFERRED) FOR NON-EMPLOYEE DIRECTORSRestricted Stock Unit • May 8th, 2019 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations
Pursuant to the AMAG Pharmaceuticals, Inc. 2019 Equity Incentive Plan through the date hereof (the “Plan”), AMAG Pharmaceuticals, Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $0.01 per share (the “Stock”) of the Company. Reference is also made to the AMAG Pharmaceuticals, Inc. Non-Employee Directors’ Deferred Compensation Program (the “Program”) and the Grantee’s deferral election thereunder.
PRODUCT SUPPLY AGREEMENT by and between PFIZER INC. and AMAG PHARMACEUTICALS, INC.Supply Agreement • May 8th, 2019 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This SUPPLY AGREEMENT (the “Agreement”), dated as of April 1, 2017 (the “Effective Date”), is by and between Pfizer Inc., a corporation with offices at 235 East 42nd St., New York, NY 10017 (“Pfizer”), and AMAG Pharmaceuticals, Inc. a corporation with offices at 1100 Winter St., Waltham, MA 02451, (“Customer”). Pfizer and Customer may be referred to herein individually as a “Party” or collectively as the “Parties.”
